The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences
Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.
The only choice for your next manuscript
The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.
Re:GEN Open is the home for your next manuscript.
Submit Your ManuscriptAnnouncements
Call for Editorial Board Members
We are recruiting Editorial Board Members to join Re:GEN Open! If you are interested in giving back to the scientific community and have a scientific background in the life or medical sciences, please contact editorial@regenopen.com for more information.
Latest Articles
The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis—A Meta-Analysis
Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Acanthamoeba Keratitis: Developing a Novel Contact Lens Disinfectant Remains an Unmet Need
P13K/AKT/mTOR Pathway-Based Novel Biomarkers for Breast Cancer
Prime Editing, a Novel Genome-Editing Tool That May Surpass Conventional CRISPR-Cas9
Same Week: Feasibility of Rapid Antiretroviral Initiation in Brazil
CRISPR Knock-in Designer: Automatic Oligonucleotide Design Software to Introduce Point Mutations by Gene Editing Methods
